Outcome measures in systemic sclerosis: An update on instruments and current research

被引：58

作者：

Khanna D. ^{[1
]}

Merkel P.A. ^{[1
]}

机构：

[1] Division of Immunology, Department of Internal Medicine, University of Cincinnati, Cincinnati, OH 45267-0563

来源：

Current Rheumatology Reports | 2007年 / 9卷 / 2期

基金：

美国国家卫生研究院;

关键词：

Pulmonary Arterial Hypertension; Scleroderma; Forced Vital Capacity; Systemic Sclerosis; Bosentan;

D O I：

10.1007/s11926-007-0010-5

中图分类号：

学科分类号：

摘要：

Substantial progress has been made in the past 10 years in the development and validation of outcome measures and refinement of trial methodology for systemic sclerosis (scleroderma, SSc). These advances in outcome measures have focused mostly on specific organ systems involved in SSc. Many of these new tools have been validated and subsequently adapted for use in multicenter clinical trials. Newer outcome measures in development are intended to more precisely quantify clinically meaningful change in specific organ systems, and some methods aim to assess overall disease burden in SSc. This review provides an update on currently used outcome measures in SSc with specific attention on newer tools and also describes methodology under development. Copyright © 2007 by Current Medicine Group LLC.

引用

页码：151 / 157

页数：6

共 50 条

[31] Update on the etiopathogenesis of systemic sclerosis
Zimmermann, Adriana Fontes
Menezes Pizzichini, Marcia Margaret
REVISTA BRASILEIRA DE REUMATOLOGIA, 2013, 53 (06) : 516 - 524
[32] Update on autoantibodies in systemic sclerosis
Walker, Jennifer G.
Fritzler, Marvin J.
CURRENT OPINION IN RHEUMATOLOGY, 2007, 19 (06) : 580 - 591
[33] Need for improved outcome measures in pulmonary arterial hypertension related to systemic sclerosis
Distler, O.
Behrens, F.
Huscher, D.
Foeldvari, I.
Zink, A.
Nash, P.
Denton, C. P.
Humbert, M.
Matucci-Cerinic, M.
Seibold, J.
Rubin, L.
Furst, D. E.
RHEUMATOLOGY, 2006, 45 (12) : 1455 - 1457
[34] Personal factors in systemic sclerosis and their coverage by patient-reported outcome measures
Mattsson, M.
Bostrom, C.
Mihai, C.
Stocker, J.
Geyh, S.
Stummvoll, G.
Gard, G.
Moller, B.
Hesselstrand, R.
Sandqvist, G.
Draghicescu, O.
Gherghe, A. M.
Voicu, M.
Distler, O.
Smolen, J. S.
Stamm, T. A.
EUROPEAN JOURNAL OF PHYSICAL AND REHABILITATION MEDICINE, 2015, 51 (04) : 405 - 421
[35] Quality Measures in Systemic Sclerosis
Aboabat, Aos
Ahmad, Zareen
Steiman, Amanda
Johnson, Sindhu R. R.
DIAGNOSTICS, 2023, 13 (04)
[36] New Patient-Reported Outcome Measures for Early Systemic Sclerosis Using the FDA Guidance on Patient Reported Outcome Measures
Khanna, Dinesh
Greene, George
Perschon, Chelsea
Lescoat, Alain
Jaeger, Emilie
Murphy, Susan
Cella, David
ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 3223 - 3225
[37] Outcome Measures for the Assessment of Cutaneous and Musculoskeletal Manifestations of Juvenile Systemic Sclerosis: An International Collaborative Scoping Review and Survey of Current Practice
Robinson, Amanda
Cakan, Mustafa
Appenzeller, Simone
Shenoi, Susan
Lu, Meiping
Sozeri, Betul
Zheng, Rongjun
Bhave, Priya
Canizares, Natalia Vasquez
Li, Suzanne
ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 4429 - 4432
[38] Outcome measures for multiple sclerosis
Osborne, Lisa
Noble, J.
Maramba, Inocencio
Jones, Kerina
Middleton, Rodden
Lyons, Ronan
Ford, David
Reed, Phil
PHYSICAL THERAPY REVIEWS, 2014, 19 (01) : 24 - 38
[39] Outcome Measures in Multiple Sclerosis
Bermel, Robert
Waldman, Amy
Mowry, Ellen M.
MULTIPLE SCLEROSIS INTERNATIONAL, 2014, 2014
[40] Current Research in Outcome Measures for Pediatric Rheumatic and Autoinflammatory Diseases
Erkan Demirkaya
Alessandro Consolaro
Hafize Emine Sonmez
Gabriella Giancane
Dogan Simsek
Angelo Ravelli
Current Rheumatology Reports, 2016, 18

← 1 2 3 4 5 →